Vycor Medical, Inc.
VYCO
$0.068
$0.00324.94%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.22% | -114.62% | -543.48% | 20.09% | 54.79% |
| Total Depreciation and Amortization | 3.29% | 3.97% | 1.30% | -1.31% | -1.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67.86% | -100.00% | 160.71% | 4.76% | -95.50% |
| Change in Net Operating Assets | 162.63% | 210.76% | 2,475.00% | 23.40% | 147.98% |
| Cash from Operations | 170.47% | 505.63% | -92.28% | 116.47% | 80.57% |
| Capital Expenditure | -25.71% | -- | -- | -2,066.67% | -3,600.00% |
| Sale of Property, Plant, and Equipment | -40.00% | -100.00% | 133.33% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25.00% | -100.00% | 133.33% | -2,066.67% | -4,100.00% |
| Total Debt Issued | -3.33% | -- | -- | -48.71% | 30.37% |
| Total Debt Repaid | 1.75% | -0.95% | -13.48% | 0.00% | -266.28% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.64% | -20.45% | -13.48% | -130.40% | -47.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.95% | 1,246.43% | -224.07% | -362.22% | 242.73% |
